Vitiligo is far more than a skin condition — it carries a heavy psychological burden that experts say is still widely underestimated. Nearly 1 in 4 people with vitiligo in Belgium experience severe depressive symptoms, and almost half report the condition affects their intimate relationships. Dermatologists and patient advocates are calling for integrated care that addresses both the skin and the mind.
Vitiligo is a chronic autoimmune disease affecting roughly 1% of Europeans, but its impact stretches well beyond depigmented skin patches. Experts are sounding the alarm that the psychological toll — including depression, anxiety, stigma, and damaged self-image — is routinely overlooked in clinical settings. Patients often wait months to a year for a diagnosis, and many are still incorrectly told the condition is untreatable, despite a growing arsenal of effective therapies.
The good news on the treatment front: options now include topical corticosteroids, calcineurin inhibitors, phototherapy, and newer JAK inhibitors that can stimulate repigmentation and slow disease progression. But experts stress that treatment requires patience — sometimes years — and that mental health support must be woven into the care model from the start.
By the Numbers:
Why it matters: The European White Paper on Vitiligo is pushing for better HCP education, earlier referrals, and care models that treat the whole patient — not just the skin. For clinicians, recognizing vitiligo's psychiatric dimensions isn't optional; it's essential to delivering meaningful care.
